Tatsuya Fujikawa
- Hepatology top 5%
- Physiology top 5%
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 3
- Cancer, Hypoxia, and Metabolism 3
-
- Growth Hormone and Insulin-like Growth Factors 3
-
- Pelvic floor disorders treatments 3
-
- Anorectal Disease Treatments and Outcomes 3
- Infectious Diseases and Tuberculosis 3
-
- Peptidase Inhibition and Analysis 3
-
- Cerebral Venous Sinus Thrombosis 3
- Co-authors
- Satoshi OzakiM. NishikibeTakahiro FukurodaM. YanoKiyofumi IshikawaHidenori ShirahaYutaka NakanishiNobuyuki Takaoka
- Journals
- Journal of Biological Chemistry (3 papers)Biochemical and Biophysical Research Communications (1 paper)The American Journal of Medicine (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Tatsuya Fujikawa
44 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Hepatology 169
- Physiology 480
- Cardiology and Cardiovascular Medicine 322
- Cancer Research 210
- Endocrinology, Diabetes and Metabolism 133
Countries citing papers authored by Tatsuya Fujikawa
This map shows the geographic impact of Tatsuya Fujikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Fujikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Fujikawa more than expected).
Fields of papers citing papers by Tatsuya Fujikawa
This network shows the impact of papers produced by Tatsuya Fujikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Fujikawa. The network helps show where Tatsuya Fujikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tatsuya Fujikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 8 | |
| 4 | 2020 | 1 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 3 | |
| 7 | 2019 | 2 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 4 | |
| 11 | 2013 | 8 | |
| 12 | 2012 | 28 | |
| 13 | 2012 | 15 | |
| 14 | 2009 | 96 | |
| 15 | 2006 | 17 | |
| 16 | 2006 | 8 | |
| 17 | 2004 | 107 | |
| 18 | 2002 | 107 | |
| 19 | 2000 | 64 | |
| 20 | Clearance of Circulating Endothelin-1 by ETB Receptors in Ratsbreakdown → | 1994 | 535 |
About Tatsuya Fujikawa
Tatsuya Fujikawa is a scholar working on Applied Microbiology and Biotechnology, Dermatology and Cancer Research, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pelvic floor disorders treatments (3 papers), Anorectal Disease Treatments and Outcomes (3 papers), Protease and Inhibitor Mechanisms (3 papers), Infectious Diseases and Tuberculosis (3 papers), Peptidase Inhibition and Analysis (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cerebral Venous Sinus Thrombosis (3 papers). The work is most often cited by research in Hepatology (169 citations), Physiology (480 citations) and Cardiology and Cardiovascular Medicine (322 citations). Tatsuya Fujikawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Satoshi Ozaki, M. Nishikibe, Takahiro Fukuroda, M. Yano, Kiyofumi Ishikawa, Hidenori Shiraha, Yutaka Nakanishi, Nobuyuki Takaoka, Naoki Ueda and Yasushi Shiratori. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.